Review of frequently used Kampo prescriptions: Part 4, Ninjin'yoeito
Open Access
- 7 October 2023
- journal article
- review article
- Published by Wiley in Traditional & Kampo Medicine
- Vol. 10 (3) , 224-252
Abstract
Background: The source of ninjin'yoeito (NYT) is considered the ‘Formulary of Bureau of Taiping People's Welfare Pharmacy’, written around 1241–52 AD. NYT is used to treat patients with chronic fatigue, malaise with qi deficiency, and exhaustion of all five parenchymatous viscera with difficulty in recovering.Key Findings: NYT formula consists of 12 crude drugs. NYT extract for medical use is covered by the National Health Insurance system of Japan for convalescence after recovery from diseases, fatigue and malaise, anorexia, perspiration during sleep, cold limbs, and anemia. Studies have shown clinical effects of NYT: treatment of anemia, cancer treatment support, frailty, cognitive dysfunction, apathy, fatigue/malaise, anorexia, and lung diseases. Preclinical studies support clinical studies; activating ghrelin‐neuropeptide Y pathway‐mediated appetite‐enhancing effects, inhibiting muscle volume loss through the Akt/mTOR pathway‐mediated hyperphosphorylation of 4E‐BP1 and FoxO1‐mediated Atrogin‐1, suppressing the hypothalamic–pituitary–adrenal axis by downregulating the sympathetic‐adrenal‐medullary axis and GABA neurons for improving sociability, promoting recovery from skeletal muscle atrophy through the activation of PGC‐1α, hematopoiesis‐promoting effects, and increasing the number of immune cells in immunocompromised models. The incidence of adverse events of NYT was reported as 3.09 or 2.03%. The most significant adverse effects of NYT are gastrointestinal disorders.Conclusion: Recently, NYT has been widely used to treat several symptoms and conditions under the National Health Insurance System of Japan. Clinical studies showed the efficacy of NYT to treat anemia, frailty, cognitive dysfunction, anorexia, apathy, and fatigue/malaise, as well as for long‐term cancer treatment support. The pharmacological mechanisms supporting its effects are also being reported.Keywords
This publication has 92 references indexed in Scilit:
- Restoration of FcRγ/Fyn signaling repairs central nervous system demyelinationJournal of Neuroscience Research, 2007
- Water-soluble extracts from Angelica acutiloba Kitagawa enhance hematopoiesis by activating immature erythroid cells in mice with 5-fluorouracil-induced anemiaExperimental Hematology, 2004
- Changes of materials that scavenge 1, 1-diphenyl-2-picrylhydrazyl radicals in plasma by per-oral administration of Kampo medicine, Ninjin-yoei-to in ratsJournal of Pharmacy and Pharmacology, 2003
- Protective Effect of Ninjin-yoei-to on Damage to Isolated Hepatocytes Following Transient Exposure to tert-Butyl HydroperoxideThe Japanese Journal of Pharmacology, 2001
- Thymus-dependent effects of a traditional chinese medicine, ren-shen-yang-rong-tang (Japanese name; Ninjin-Youei-To), in autoimmune MRL/MP-Ipr/Ipr miceInternational Journal of Immunopharmacology, 1996
- Treatment effect of a traditional Chinese medicine, Ren-shen-yang-rong-tang (Japanese name: Ninjin-Youeito), on autoimmune MRL/MP-lpr/lpr miceInternational Journal of Immunopharmacology, 1993
- Protective effect of ren-shen-yang-rong-tang (Ninjin-Youei-to) in mice with drug-induced leukopenia against Pseudomonas aeruginosa infectionInternational Journal of Immunopharmacology, 1992
- A traditional Chinese herbal medicine, Ren-shen-yang-rong-tang (Japanese-name: Ninjin-yoei-to) augments the production of granulocyte-macrophage colony-stimulating factor from human peripheral blood mononuclear cells in vitroInternational Journal of Immunopharmacology, 1991
- Structural Characterization and Antitumor Activity of a Pectic Polysaccharide from the Roots ofAngelica acutiloba1Planta Medica, 1990
- Effect of a traditional chinese herbal medicine, ren-shen-yang-rong-tang (Japanese name: ninjin-youei-to) on hematopoietic stem cells in miceInternational Journal of Immunopharmacology, 1989